Table 10 Use of serum free β-subunit as a tumor marker for detection of malignancies.
From: New discoveries on the biology and detection of human chorionic gonadotropin
Malignancy | Patients | Sensitivity (> 3 fmol/ml) |
|---|---|---|
Ovarian cancer | 150 | 38% average of 3 reports |
Cervical cancer | 60 | 37% average of 2 reports |
Endometrial cancer | 55 | 33% average of 2 reports |
Vulvar | 50 | 38% single report |
Bladder cancer | 99 | 38% average of 2 reports |
Lung cancer | 177 | 18% average of 2 reports |
Colorectal cancer | 436 | 17% average of 2 reports |
TOTAL | 1152 | 30% average of 16 reports |